1. Home
  2. OMER vs IMKTA Comparison

OMER vs IMKTA Comparison

Compare OMER & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omeros Corporation

OMER

Omeros Corporation

N/A

Current Price

$19.89

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

N/A

Current Price

$86.11

Market Cap

1.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
OMER
IMKTA
Founded
1994
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Food Chains
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.6B
IPO Year
2008
1994

Fundamental Metrics

Financial Performance
Metric
OMER
IMKTA
Price
$19.89
$86.11
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $27.50
N/A
AVG Volume (30 Days)
★ 1.3M
82.6K
Earning Date
11-12-2026
11-25-2026
Dividend Yield
N/A
★ 0.77%
EPS Growth
★ 98.15
N/A
EPS
★ 0.77
N/A
Revenue
$29,868,000.00
★ $5,334,032,609.00
Revenue This Year
N/A
N/A
Revenue Next Year
$73.58
N/A
P/E Ratio
$24.83
★ $15.91
Revenue Growth
N/A
★ N/A
52 Week Low
$4.06
$67.17
52 Week High
$21.24
$95.62

Technical Indicators

Market Signals
Indicator
OMER
IMKTA
Relative Strength Index (RSI) 59.63 57.03
Support Level $18.00 $82.64
Resistance Level $21.24 $90.01
Average True Range (ATR) 0.76 1.76
MACD -0.12 0.26
Stochastic Oscillator 55.90 69.39

Price Performance

Historical Comparison
OMER
IMKTA

About OMER Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: